Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 15, 2024
[Development of a prediction model for incidence of diabetic foot in patients with type 2 diabetes and its application based on a local health data platform]Y X Yu, M Zhang, X W Chen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 22, 2024
[Development and application of a prediction model for incidence of diabetic retinopathy in newly diagnosed type 2 diabetic patients based on regional health data platform]X W Chen, L J Liu, Y X Yu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 22, 2026
[Exploration on the application of perineal lateral arc-shaped incision in the resection of complex tumors on the lateral side of the pelvic floor]L L Guo, G C Wang, W C Ai, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 9, 2017
[Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia]W Y Li, J S Chen, Q Zhao, et al.
Genetics and Molecular Research : GMR|December 17, 2013
Critical evaluation of transcription factor Atf2 as a candidate modulator of alcohol preference in mouse and human populationsL S Wang, Y Jiao, Y Huang, et al.
The Review of Scientific Instruments|March 5, 2008
Intense beam production of highly charged heavy ions by the superconducting electron cyclotron resonance ion source SECRALH W Zhao, L T Sun, X Z Zhang, et al.
The Review of Scientific Instruments|March 3, 2010
New development of advanced superconducting electron cyclotron resonance ion source SECRAL (invited)H W Zhao, L T Sun, W Lu, et al.
The Review of Scientific Instruments|March 3, 2010
Production of highly charged ion beams with SECRALL T Sun, H W Zhao, W Lu, et al.
ESMO Open|July 26, 2024
Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trialsF-R Liu, X-L Wei, W-N Feng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2013
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinomaX Wu, P Y Huang, P J Peng, et al.
Pageof 20